Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10

Journal of Neuro-Oncology

Volumn 40, Issue 2, 1998, Pages 113-122

  Wagner, Sven ^a   Stegen, Carola ^a   Bouterfa, Hakim ^a   Huettner, Claudia ^b   Kerkau, Siglinde ^a   Roggendorf, Wolfgang ^a   Roosen, Klaus ^a   Tonn, Joerg Christian ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

Author keywords

Glioma; Interleukin 10; Matrix metalloproteinases; Proteinase inhibitors; Tumor invasion

Indexed keywords

COLLAGENASE; ELASTASE; INTERLEUKIN 10; MATRIGEL; MATRILYSIN; MATRIX METALLOPROTEINASE; SERINE PROTEINASE; STROMELYSIN;

ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; DOSE RESPONSE; GLIOMA CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BRAIN NEOPLASMS; CELL LINE; ENDOPEPTIDASES; EXTRACELLULAR MATRIX; GLIOMA; HUMANS; INTERLEUKIN-10; METALLOENDOPEPTIDASES; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0032406072     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006146405880     Document Type: Article

References (47)

1. Liotta LA: Tumor invasion and metastasis. Role of the extracellular matrix: Rhoads Memorial Award Lecture. Cancer Res 46: 1-7, 1986
2. Romanic AM, Madri JA: Extracellular matrix-degrading proteinases in the nervous system. Brain Pathol 4: 145-156, 1994
3. Nagano N, Sasaki H, Aoyagi M, Hirakawa K: Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol (Berl) 86: 117-125, 1993
4. Crabbe T, Smith B, O'Connell J, Docherty A: Human progelatinase A can be activated by matrilysin. FEBS Lett 345: 14-16, 1994
5. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC: Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci USA 93: 9748-9753, 1996
6. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Gabisa S: Effect of plasminogen activator (urokinase), plasm in, and thrombin on glycoprotein and collagenous components of basement membrane, Cancer Res 41: 4629-4636, 1981
7. Mackay AR, Corbitt RH, Hartzler JL, Thorgeirsson UP: Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases. Cancer Res 50: 5997-6001, 1990
8. Vasalli J-D, Pepper MS: Membrane proteases in focus. Nature 370: 14-15, 1994
9. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 370: 61-65, 1994
10. Takino T, Sato H, Shinagawa A, Seiki M: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. J Biol Chem 270: 23013-23020, 1995
11. Yu M, Sato H, Seiki M, Thompson EW: Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by Concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res 55: 3272-3277, 1995
12. Lewalle JM, Munaut C, Pichot B, Cataldo D, Baramova E, Foidart JM: Plasma membrane-dependent activation of gelatinase A in human vascular endothelial cells. J Cell Physiol 165: 475-483, 1995
13. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI: Mechanism of cell surface activation of 72 kDa type IV collagenase: isolation of the activated form of the membrane metalloprotease. J Biol Chem 270: 5331-5338, 1995
14. Nakano A, Tani E, Miyazaki K, Yamamoto Y, Furuyama J: Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J Neurosurg 83: 298-307, 1995
15. Uhm JH, Dooley NP, Villemure J-G, Yong VW: Glioma invasion in vitro: regulation by matrix motalloprotease-2 and protein kinase C. Clin Exp Metast 14: 421-433, 1996
16. Sawaya RE, Yamamoto M, Gokaslan ZL, Wang SW, Mohanaman S, Fuller GN, McCutcheon IE, Stetler-Stevenson WG, Nicolson GL, Rao JS: Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo. Clin Exp Metast 14: 35-42, 1990
17. Rutka JT, Matzsuzawa K, Hubbard SL, Kukuyama K, Becker L, Stetler-Stevenson W, Edwards DR, Dirks PB: Expression of TIMP-1, TIMP-2, 72- and 92-kDa type IV collagenase transcripts in human astrocytoma cell lines: correlation with astrocytoma cell invasiveness. Int J Onc 6: 877-884, 1995
18. Matsuzawa K, Fukuyama K, Hubbard SL, Dirks PB, Rutka JT: Transfection of an invasive human astrocytoma cell line with a TIMP-1 cDNA: modulation of astrocytoma invasive potential. J Neuropath Exp Neurol 55: 88-96, 1996
19. Wilson CL, Heppner K, Labosky PA, Hogan BLM, Matrisian LM: Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94: 1402-1407, 1997
20. Huettner G, Paulus W, Roggendorf W: Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol 146: 317-322, 1995
21. Taga K, Tosato G: IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 148: 1143-1148, 1992
22. Huettner C, Czub S, Kerkau S, Roggendorf W, Tonn J-C: Interleukin 10 is expressed in human gliomas in vivo and increases glioma cell proliferation and motility in vitro. Anticancer Res, 17: 3217-3224, 1997
23. Reitamo S, Remitz A, Tamai K, Uitto J: Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts. J Clin Invest 94: 2489-2492, 1994
24. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidiniumthycyanide-phenol-chlorophorm extraction. Anal Biochem 162: 156-159, 1987
25. Herron GS, Banda MJ, Clark EJ, Gavrilovic J, Werb Z: Secretion of metalloproteinases by stimulated capillary endothelial cells. J Biol Chem 261: 2814-2818, 1986
26. Borden P, Heller RA: Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix metalloproteinases. Crit Rev Eurkaryot Gene Expr 7: 159-178, 1997
27. Cassatella MA, Meda L, Gasperini S, Calzetti F, Bonora S: Interleukin-10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation. J Exp Med 179: 1695-1699, 1994
28. Borchers AH, Sanders LA, Bowden GT: Regulation of matrilysin in cells of squamous cell carcinoma by E-cadherin-mediated cell-cell contact. J Cancer Res Clin Oncol 123: 13-20, 1997
29. Stearns ME, Wang M, Stearns M: IL-10 blocks collagen IV invasion by 'invasion stimulating factor' activated PC-3 ML cells: upregulation of TIMP-1 expression. Onc Res 7: 157-163, 1995
30. Overall CM, Wrana JL, Sodek J: Transcriptional and post-transcriptional regulation of 72 kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J Biol Chem 266: 14064-14071, 1991
31. Boone TC, Johnson MJ, DeClerck YA, Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinase. Proc Natl Acad Sci USA 87: 2800-2804, 1990
32. DeClerck YA, Yean T-D, Ratzkin BJ, Lu HS, Langley KE: Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264(29): 17445-174543, 1989
33. Murphy G, Cawston T, Reynols J: An inhibitor of collagenase from human amniotic fluid: purification, characterization and action on metalloproteinases. Biochem J 195: 167-170, 1981
34. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2): a new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374-17378, 1989
35. Thorgeirsson UP, Liotta LA, Kalebic T, Margulies IM, Thomas K, Rios-Candelore M, Russo RG: Effect of natural prolease inhibitor and a chemoattractant on tumor cell invasion in vitro. J Natl Cancer Inst 69: 1049-1057, 1982
36. Mignatti P, Robbins E, Rifkin DB: Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell 47: 478-498, 1986
37. Schultz RM, Silberman S, Persky B, Bajkowski AS, Carmichael DF: Inhibition of human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res 48: 5539-5545, 1988
38. Alvarez OA, Carmichael DF, DeClerck YA: Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 82: 589-595, 1990
39. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in scrum. FEBS Lett 298(1): 29-32, 1992
40. Uria JA, Ferrando AA, Velasco G, Freije JMP, Lopez-Otin C: Structure and expression in breast tumours of human TIMP-3, a new member of the metalloproteinase family. Cancer Res 54: 2091-2094, 1994
41. Shi YR, Greene J, Wang M, Xiao G, Kiu YE: Loss of expression of TIMP-4, a novel human tissue inhibitor of metalloproteinase, in human breast cancer malignant progression. In: Proteases and Protease Inhibitors: AACR Special Conference: Marriott's Bay Point Resort, Panama City Beach A-10, 1996
42. Cuvelier A, Kuntz C, Sesboüé R, Muir JF, Martin JP: Les métalloprotéinases de la matrice extracellulaire (MMP): structure et activité. Rev Mal Resp 14: 1-10, 1997
43. Brown PD: Matrix metalloproteinase inhibitor: a novel class of anticancer agents. Adv Enz Regul 35: 293-301, 1995
44. Taraboletti G, Garofalo A, Belotti D, Drudis T, Borsotti P, Scaziani E, Brown PD, Giavazzi R: Inhibition of angiogenesis and murine haemangioma. J Natl Cancer Inst 87: 293-298, 1995
45. Uhm JH, Dooley NP, Villemure J-G, Yong VW: Mechanisms of glioma invasion: role of matrix metalloproteinases. Can J Neurol Sci 24: 3-15, 1997
46. Yamamoto H, Itoh F, Hinoda Y, Imai K: Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int J Cancer 61: 218-222, 1995
47. Ahmad S, Mineta T, Martuza RL, Glazer RI: Antisense expression of protein kinase Ca inhibits the growth and tumorigenicity of human glioblastoma cells. Neurosurgery 35: 904-909, 1994